Distribution 2019
***
***
***
Filed under: Drugs and Pharma | Tagged: Medicare Part D |
The “Medical Executive-Post” is about connecting doctors, health care executives and modern consulting advisors. It’s about free-enterprise, business, practice, policy, personal financial planning and wealth building capitalism. We have an attitude that’s independent, outspoken, intelligent and so Next-Gen; often edgy, usually controversial. And, our consultants “got fly”, just like U. Read it! Write it! Post it! “Medical Executive-Post”. Call or email us for your FREE advertising and sales consultation TODAY [678.779.8597] Email: MarcinkoAdvisors@outlook.com
Suite #5901 Wilbanks Drive, Norcross, Georgia, 30092 USA [1.678.779.8597]. Our location is real and we are now virtually enabled to assist new long distance clients and out-of-town colleagues.
If you want the opportunity to work with leading health care industry insiders, innovators and watchers, the “ME-P” may be right for you? We are unbiased and operate at the nexus of theoretical and applied R&D. Collaborate with us and you’ll put your brand in front of a smart & tightly focused demographic; one at the forefront of our emerging healthcare free marketplace of informed and professional “movers and shakers.” Our Ad Rate Card is available upon request [678-779-8597].
Blog at WordPress.com. WP Designer.



RUN FROM Part C
https://pnhp.org/news/medicare-advantage-plans-are-ripping-off-taxpayers-by-the-billions/
Dr. David E. Marcinko MBA
LikeLike
Medicare Part D Common Specialty Medications Out-of-Pocket Cost
• Revlimid: $17,142
• Ibrance: $13,865
• Xtandi: $9,882
• Tecfidera: $7,394
• Humira: $5,911
Source: GoodRx, “Medicare Part D Patients May Pay More Than $15K for Their Specialty Medications”, June 2, 2021
FRANKIE
LikeLike
Medicare drug negotiations
https://www.msn.com/en-us/news/politics/a-cornerstone-of-democrats-agenda-is-suddenly-in-deep-trouble/ar-AAOurOH?li=BBnbfcL
Doris
LikeLike